首页> 外文期刊>clinical nuclear medicine >Tc-99m Sestamibi Scintimammography in the Evaluation of Response of Breast Carcinoma to Chemotherapy
【24h】

Tc-99m Sestamibi Scintimammography in the Evaluation of Response of Breast Carcinoma to Chemotherapy

机译:Tc-99m Sestamibi Scintimammography in the Evaluation of Response of Breast Carcinoma to Chemotherapy

获取原文
           

摘要

A 44-year-old premenopausal woman had a T3N0M0 breast cancer in the inner superior quadrant of the left breast. Her biopsy revealed a histologic grade III and nuclear grade II invasive ductal carcinoma with foci of comedocarcinoma. The patient was placed on three cycles of neoadjuvant chemotherapy with cyclophosphamide, epirubicin, and fluorouracil (FEC). Scintimammography, mammography, and histopathologic evaluation were obtained prior to and after treatment to evaluate the tumor response to chemotherapy. After modified radical mastectomy, histopathology demonstrated only 10 of viable tumor cells, 80 of collagenization, and 10 of tumor necrosis.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号